These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19241619)

  • 61. FDA notifications. FDA approves new formulation of Lexiva.
    AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
    [No Abstract]   [Full Text] [Related]  

  • 62. FDA notifications. FDA approves pediatric efficacy supplement for didanosine capsules.
    AIDS Alert; 2008 Nov; 23(11):129. PubMed ID: 19043871
    [No Abstract]   [Full Text] [Related]  

  • 63. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 64. FDA advisory committee approves Selzentry.
    AIDS Patient Care STDS; 2009 Nov; 23(11):987. PubMed ID: 19938371
    [No Abstract]   [Full Text] [Related]  

  • 65. FDA approves once-daily efavirenz formulation, revised labeling.
    AIDS Treat News; 2002 Mar; (378):7. PubMed ID: 11965921
    [No Abstract]   [Full Text] [Related]  

  • 66. FDA approves three generics.
    AIDS Patient Care STDS; 2009 Apr; 23(4):305. PubMed ID: 19358692
    [No Abstract]   [Full Text] [Related]  

  • 67. FDA approves generic abacavir sulfate tablets.
    AIDS Alert; 2006 Dec; 21(12):139-40. PubMed ID: 17233093
    [No Abstract]   [Full Text] [Related]  

  • 68. FDA approves new upgraded Gardasil 9.
    Kirby T
    Lancet Oncol; 2015 Feb; 16(2):e56. PubMed ID: 25532625
    [No Abstract]   [Full Text] [Related]  

  • 69. FDA approves 'farmaceutical' drug from transgenic chickens.
    Sheridan C
    Nat Biotechnol; 2016 Feb; 34(2):117-9. PubMed ID: 26849497
    [No Abstract]   [Full Text] [Related]  

  • 70. FDA approves Aptivus (tipranavir).
    Pham PA
    Hopkins HIV Rep; 2005 Jul; 17(4):6-7. PubMed ID: 16419308
    [No Abstract]   [Full Text] [Related]  

  • 71. FDA approves nexium for use in children ages 1-11 years.
    Lang L
    Gastroenterology; 2008 May; 134(5):1282. PubMed ID: 18471499
    [No Abstract]   [Full Text] [Related]  

  • 72. FDA approves two combo brand-name AIDS drugs.
    Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
    [No Abstract]   [Full Text] [Related]  

  • 73. New drugs: milnacipran hydrochloride, fesoterodine fumarate, and silodosin.
    Hussar DA
    J Am Pharm Assoc (2003); 2009; 49(2):347-50. PubMed ID: 19289354
    [No Abstract]   [Full Text] [Related]  

  • 74. FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
    James JS
    AIDS Treat News; 2004 Jul; (403):6. PubMed ID: 15386855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FDA approves tipranavir.
    IAPAC Mon; 2005 Jul; 11(7):190. PubMed ID: 16676422
    [No Abstract]   [Full Text] [Related]  

  • 76. FDA Approves Vilobelimab for Emergency Use in Hospitalized Adults.
    Harris E
    JAMA; 2023 May; 329(18):1544. PubMed ID: 37075230
    [No Abstract]   [Full Text] [Related]  

  • 77. FDA center issues new guidelines, approves drugs.
    Printz C
    Cancer; 2021 Mar; 127(6):826. PubMed ID: 33689177
    [No Abstract]   [Full Text] [Related]  

  • 78. FDA approves 100th monoclonal antibody product.
    Mullard A
    Nat Rev Drug Discov; 2021 Jul; 20(7):491-495. PubMed ID: 33953368
    [No Abstract]   [Full Text] [Related]  

  • 79. FDA approves first complement factor D inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 May; 23(5):329. PubMed ID: 38605116
    [No Abstract]   [Full Text] [Related]  

  • 80. Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?
    Doody RS; Skerjanec S
    J Prev Alzheimers Dis; 2023; 10(3):344-345. PubMed ID: 37357269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.